摘要:
Benzofurancarboxamides having basic substituents, of the formula I ##STR1## in which R.sup.1 and X have the meanings stated in the description, a process for the preparation thereof, and therapeutic agents containing them.
摘要:
Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles of the formula ##STR1## where n and A have the meanings stated in the description, and the preparation thereof are described. The compounds are suitable for controlling diseases.
摘要:
Benzofurancarboxamides having basic substituents, of the formula I ##STR1## in which R.sup.1 and X have the meanings stated in the description, a process for the preparation thereof, and therapeutic agents containing them.
摘要:
2-Hydroxy-3-phenoxy-propyl-substituted piperazines of the formula I ##STR1## in which R.sup.1 -R.sup.5, Y, m and n have the meaning indicated in the description, and the preparation thereof are described. The novel compounds are suitable for the therapy of oxygen deficiency diseases of the brain.
摘要:
Compounds of the formula ##STR1## where R.sup.1, R.sup.2, R.sup.3, R.sup.4 and A have the meanings stated in the specification, as well as the use thereof for controlling diseases, are described.
摘要:
Compounds of the formula ##STR1## where R and A have the meanings given in the description, and their use in the treatment of disorders are described.
摘要:
where R—R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要:
Carboxylic acid derivatives where R-R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要:
Carboxylic acid derivatives where R-R6, X, Y and Z have the meanings stated in the description, and the preparation thereof, are described. The novel compounds are suitable for controlling diseases.
摘要:
A compound of the formula pharmaceutically acceptable salts and enantiomers thereof and pharmaceutical compositions containing this compound, its pharmaceutically acceptable salts and enantiomers are claimed.